Case Study: Discussing the Regulatory Pathway to Clinic
Time: 9:30 am
day: Day Two Morning
Details:
- Highlighting the journey of advancing gene-edited iPSC therapies from preclinical to clinical trials, sharing lessons learned and insights on meeting regulatory and CMC expectations
